Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
66.79
USD
-0.25%
Market Closed
Market Cap:
$3.2B
Relative Value
The Relative Value of one
PBH
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 66.79 USD,
Prestige Consumer Healthcare Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PBH Relative Value
HIDDEN
Multiples Across Competitors
PBH Competitors Multiples
Prestige Consumer Healthcare Inc Competitors
Prestige Consumer Healthcare Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
3.2B USD | 2.9 | 16.9 | 11.8 | 12.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.7B USD | 15.1 | 47.6 | 32.1 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
293.8B CHF | 4.8 | 31.4 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
242.2B GBP | 5.6 | 32.4 | 17.9 | 25.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.3B CHF | 5.7 | 22.8 | 14 | 18 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.6B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
91.5B GBP | 2.8 | 16.2 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
